Vitamin D3 and B12 supplementation in pregnancy

Diabetes Res Clin Pract. 2021 Apr:174:108728. doi: 10.1016/j.diabres.2021.108728. Epub 2021 Mar 1.

Abstract

Aim: To assess the efficacy of vitamin D3 or B12 supplementation during pregnancy.

Methods: Pregnant women at 6-14 weeks in the intervention arm received oral high dose intermittent vitamin D3 and/or low dose B12 supplementation if they had vitamin D or vitamin B12 deficiency. The control arm received prescribed dietary instruction only. An additional observational arm for those mothers at booking with normal vitamin D and vitamin B12 level was also recruited. All groups received standard care during pregnancy.

Results: The primary endpoint of either vitamin D or B12 at term was not met. At baseline 25% participants in both the interventional and control arms had severe D deficiency (<30 nmol/l), reducing to under 3.4% in both groups. No maternal differences in vitamin D or B12 levels were found at delivery between the intervention, control, or observational groups. No significant difference in any of the pregnancy or birth outcomes was observed between three groups.

Conclusions: In this study, oral supplementation of high dose intermittent vitamin D or low dose vitamin B12 regime failed to correct the relevant nutritional deficiencies in Bangladeshi pregnant women as per protocol. Both dietary supplementation and high dose vitamin D corrected severe vitamin deficiency.

Keywords: Oral supplement; Pregnancy outcomes; Vitamin B12; Vitamin D3.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Cholecalciferol / pharmacology
  • Cholecalciferol / therapeutic use*
  • Dietary Supplements / standards*
  • Female
  • Humans
  • Pilot Projects
  • Pregnancy
  • Pregnancy Complications
  • Vitamin B 12 / pharmacology
  • Vitamin B 12 / therapeutic use*
  • Young Adult

Substances

  • Cholecalciferol
  • Vitamin B 12